Patrick Stucki
Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry
Viktorin-Baier P, Zürn K, Güsewell S, Schiefer J, Blick N, Müntener M, Stucki P, Suter S, Prikler L, Hochreiter W, Thoeni A, Schwab C, Plasswilm L, Schmid H, Putora P, Engeler D. Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry. BJU Int 2020; 125:827-835.
Feb 12, 2020Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry
Feb 12, 2020BJU Int 2020; 125:827-835
Viktorin-Baier Pascal, Zürn Karin, Güsewell Sabine, Schiefer Johann, Blick Nadja, Müntener Michael, Stucki Patrick, Suter Stefan, Prikler Ladislav, Hochreiter Werner, Thoeni Armin, Schwab Christoph, Plasswilm Ludwig, Schmid Hans-Peter, Putora Paul Martin, Engeler Daniel
PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator
Engeler D, Schmid H, Plasswilm L, Schiefer J, Stucki P, Suter S, Prikler L, Hochreiter W, Thöni A, Schwab C, Putora P. PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol 2015; 191:787-791.
Jun 23, 2015PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator
Jun 23, 2015Strahlenther Onkol 2015; 191:787-791
Engeler Daniel, Schmid Hans-Peter, Plasswilm Ludwig, Schiefer Johann, Stucki Patrick, Suter Stefan, Prikler Ladislav, Hochreiter Werner, Thöni Armin F, Schwab Christoph, Putora Paul Martin